Dna X (SONM) Share-based Compensation (2018 - 2025)
Dna X's Share-based Compensation history spans 8 years, with the latest figure at $159000.0 for Q4 2025.
- Quarterly results put Share-based Compensation at $159000.0 for Q4 2025, down 55.34% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 1.05% YoY), and the annual figure for FY2025 was $1.5 million, up 1.05%.
- Share-based Compensation for Q4 2025 was $159000.0 at Dna X, down from $166000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q4 2023 to a low of $159000.0 in Q4 2025.
- The 5-year median for Share-based Compensation is $324500.0 (2021), against an average of $394550.0.
- The sharpest move saw Share-based Compensation soared 177.35% in 2023, then tumbled 69.07% in 2024.
- Year by year, Share-based Compensation stood at $325000.0 in 2021, then increased by 27.69% to $415000.0 in 2022, then soared by 177.35% to $1.2 million in 2023, then tumbled by 69.07% to $356000.0 in 2024, then crashed by 55.34% to $159000.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods came in at $159000.0, $166000.0, and $926000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.